The Contradictions of the State Policy on Regulation of Prices on Medicines: Problems and Ways of Their Solving

I. Kotlyarov and A. Balashov

Voprosy Ekonomiki, 2011, issue 10

Abstract: The article analyzes the existing model of regulation of prices on medicines in the Russian Federation. Problems of this model are described (especially the fact that it stimulates elimination of cheaper medicines from the product range of pharmacies and pharmaceutical distributors and hinders investments into local development of innovative medicines). Ways to solve these problems are proposed. It is demonstrated that all medicines should be divided into three groups according to their price, and for each group a special method of price regulation should be used. It is also proposed to implement a guaranteed level of profitability of local developers of innovative medicines.

Date: 2011
References: Add references at CitEc
Citations:

Downloads: (external link)
https://www.vopreco.ru/jour/article/viewFile/1145/1146 (application/pdf)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:nos:voprec:y:2011:id:1145

DOI: 10.32609/0042-8736-2011-10-142-155

Access Statistics for this article

More articles in Voprosy Ekonomiki from NP Voprosy Ekonomiki
Bibliographic data for series maintained by NEICON ().